Study shows strong long-term survival rates for patients with GIST

Posted by on February 20, 2017 12:42 pm
Categories: health

Nearly one in four patients with incurable gastrointestinal stromal tumors (GIST) treated with Gleevec will survive 10 years, a new report outlines.

Leave a Reply

Your email address will not be published. Required fields are marked *